COVID-19 vaccines and anaphylaxis-evaluation with skin prick testing, basophil activation test and Immunoglobulin E.

Csuth, Àgnes; Nopp, Anna; Storsaeter, Jann; Nilsson, Lennart; Jenmalm, Maria C

Csuth, Àgnes; Nopp, Anna; Storsaeter, Jann; Nilsson, Lennart; Jenmalm, Maria C.

Afiliação

Csuth À; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.
Nopp A; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Storsaeter J; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
Nilsson L; Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden.
Jenmalm MC; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.

Clin Exp Allergy ; 52(6): 812-819, 2022 06.

Article em En | MEDLINE | ID: mdl-35384115

Assuntos

Anafilaxia; COVID-19; Anafilaxia/diagnóstico; Anafilaxia/etiologia; Teste de Degranulação de Basófilos; Basófilos; COVID-19/diagnóstico; Vacinas contra COVID-19/efeitos adversos; Humanos; Imunoglobulina E; Testes Cutâneos

Palavras-chave

COVID-19; anaphylaxis; basophil activation test; polyethylene glycol; skin prick test; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Anafilaxia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Clin Exp Allergy Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google